Update on a phase 2 study of idelalisib in combination with rituximab in treatment-naive patients ≥ 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) Meeting Abstract


Authors: O'Brien, S.; Lamanna, N.; Kipps, T. J.; Flinn, I. W.; Zelenetz, A. D.; Burger, J. A.; Holes, L. M.; Cho, Y. J.; Dubowy, R. L.; Coutre, S. E.
Abstract Title: Update on a phase 2 study of idelalisib in combination with rituximab in treatment-naive patients ≥ 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349243505032
PROVIDER: wos
DOI: 10.1182/blood.V124.21.1994.1994
Notes: Meeting Abstract: 1994 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz
Related MSK Work